Plotting the way forward for {admiralmetabolic} #5
Replies: 5 comments 7 replies
-
From the top of my head, I'm thinking that oral glucose tolerance test (OGTT) and continuous glucose monitoring (CGM) might be relevant in relation to diabetes, and diet registration and physical activity can be relevant in the case of obesity. |
Beta Was this translation helpful? Give feedback.
-
ObesityAttendees to the 2024-07-03 meeting shared that when working in this indication, SDTM datasets that are relevant are:
We'd be looking to create test data for these to run our examples/templates/tests. Even if these datasets are already existing in Correspondingly, the following ADaM datasets could be relevant for
We'd be looking to create templates and vignettes showcasing how to build the datasets, and showcasing any |
Beta Was this translation helpful? Give feedback.
-
DiabetesAttendees to the 2024-07-03 meeting discussed the following:
|
Beta Was this translation helpful? Give feedback.
-
I have been looking up publicly available protocols previously used for obesity trials, and from that found that some common endpoints used are:
In relation to DXA / DEXA, I am unsure if anything if any functions are needed, but I could imagine a vingette being useful. I will send the links to some of the protocols in our teams channel. |
Beta Was this translation helpful? Give feedback.
-
@manciniedoardo As it would sound strange at first on clinging to Excel, but it will be much easier to work on specifying data structure with an Excel/Google Worksheet. We can also extract the structure easier in the future. I also think it will be easier to put use cases on a wiki page here on the github repo. |
Beta Was this translation helpful? Give feedback.
-
Please use this space to share any thoughts/comments/opinions regarding what we should focus on for our first {admiralmetabolic} release.
If you have experience in the metabolism/obesity TA, these leading questions could help guide your thought:
The tools we provide in {admiralmetabolic} will hopefully aim to address any answers to the questions above.
The {admiralmetabolic} package will also provide test data to play around with said tools and generate ADaMs pertinent to the TA. Is there any TA-specific test data that we should create, over and above what is in pharmaversesdtm? This could include completely new datasets or edited versions of existing ones (e.g. to introduce obese patients).
We can use your comments on the above to inform our way forward 😄
Beta Was this translation helpful? Give feedback.
All reactions